ID

29898

Descrizione

Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00446511

collegamento

https://clinicaltrials.gov/show/NCT00446511

Keywords

versioni (2)
  1. 26/04/18 26/04/18 -
  2. 20/09/21 20/09/21 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

26 aprile 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hypertension NCT00446511

Inglese

Eligibility Hypertension NCT00446511

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
successful completion of 12 weeks of double-blind treatment in core protocol cval489k2302.
Descrizione

Therapeutic procedure Double-Blind Method Successful Completed

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0013072
UMLS CUI [1,3]
C1272703
UMLS CUI [1,4]
C0205197
patients participating in study cval489k2302 who may have discontinued prematurely due to uncontrolled hypertension defined as mssbp > 20%, but < 25% above the 95th percentile for age, gender, and height after visit 5, qualifies a patient for entry into this extension study.
Descrizione

Study Subject Participation Status Clinical Trial Discontinued | Uncontrolled hypertension | Sitting systolic blood pressure mean | Age | Gender | Body Height

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0008976
UMLS CUI [1,3]
C1444662
UMLS CUI [2]
C1868885
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
UMLS CUI [4]
C0001779
UMLS CUI [5]
C0079399
UMLS CUI [6]
C0005890
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
renal artery stenosis.
Descrizione

Renal Artery Stenosis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0035067
current diagnosis of heart failure (nyha class ii-iv).
Descrizione

Heart failure New York Heart Association Classification

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C1275491
second or third degree heart block without a pacemaker.
Descrizione

Second degree atrioventricular block | Complete atrioventricular block | Artificial cardiac pacemaker Absent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0264906
UMLS CUI [2]
C0151517
UMLS CUI [3,1]
C0030163
UMLS CUI [3,2]
C0332197
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
Descrizione

Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0741212
clinically significant valvular heart disease.
Descrizione

Heart valve disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018824
patient that demonstrates clinically significant ecg abnormalities other than those associated with left ventricular hypertrophy and av block controlled with a pacemaker.
Descrizione

ECG abnormality | Exception Left Ventricular Hypertrophy | Atrioventricular Block Controlled by Artificial cardiac pacemaker

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1832603
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0149721
UMLS CUI [3,1]
C0004245
UMLS CUI [3,2]
C0332298
UMLS CUI [3,3]
C0030163
previous solid organ transplantation except renal, liver or heart transplantation. renal, liver or heart transplant must have occurred at least 6 months prior to enrollment. patient must be on stable doses of immunosuppressive therapy for 3 months and deemed clinically stable by the investigator.
Descrizione

Solid organ transplant | Exception Kidney Transplantation | Exception Transplantation of liver | Exception Heart Transplantation | Therapeutic immunosuppression Dosage Stable | Patient Stable status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0730400
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0022671
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023911
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0018823
UMLS CUI [5,1]
C0021079
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0205360
UMLS CUI [6,1]
C0030705
UMLS CUI [6,2]
C0205360
patients who experienced any adverse events considered serious and drug related in protocol cval489k2302.
Descrizione

Serious Adverse Event | Adverse reaction to drug

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1519255
UMLS CUI [2]
C0041755
other protocol-defined inclusion/exclusion criteria applied to the study.
Descrizione

Eligibility Criteria Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Ritorna all'inizio della pagina

Similar models

Eligibility Hypertension NCT00446511

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Therapeutic procedure Double-Blind Method Successful Completed
Item
successful completion of 12 weeks of double-blind treatment in core protocol cval489k2302.
boolean
C0087111 (UMLS CUI [1,1])
C0013072 (UMLS CUI [1,2])
C1272703 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
Study Subject Participation Status Clinical Trial Discontinued | Uncontrolled hypertension | Sitting systolic blood pressure mean | Age | Gender | Body Height
Item
patients participating in study cval489k2302 who may have discontinued prematurely due to uncontrolled hypertension defined as mssbp > 20%, but < 25% above the 95th percentile for age, gender, and height after visit 5, qualifies a patient for entry into this extension study.
boolean
C2348568 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C1868885 (UMLS CUI [2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C0001779 (UMLS CUI [4])
C0079399 (UMLS CUI [5])
C0005890 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
Renal Artery Stenosis
Item
renal artery stenosis.
boolean
C0035067 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
current diagnosis of heart failure (nyha class ii-iv).
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Second degree atrioventricular block | Complete atrioventricular block | Artificial cardiac pacemaker Absent
Item
second or third degree heart block without a pacemaker.
boolean
C0264906 (UMLS CUI [1])
C0151517 (UMLS CUI [2])
C0030163 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC
Item
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
boolean
C0003811 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0741212 (UMLS CUI [2])
Heart valve disease
Item
clinically significant valvular heart disease.
boolean
C0018824 (UMLS CUI [1])
ECG abnormality | Exception Left Ventricular Hypertrophy | Atrioventricular Block Controlled by Artificial cardiac pacemaker
Item
patient that demonstrates clinically significant ecg abnormalities other than those associated with left ventricular hypertrophy and av block controlled with a pacemaker.
boolean
C1832603 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0149721 (UMLS CUI [2,2])
C0004245 (UMLS CUI [3,1])
C0332298 (UMLS CUI [3,2])
C0030163 (UMLS CUI [3,3])
Solid organ transplant | Exception Kidney Transplantation | Exception Transplantation of liver | Exception Heart Transplantation | Therapeutic immunosuppression Dosage Stable | Patient Stable status
Item
previous solid organ transplantation except renal, liver or heart transplantation. renal, liver or heart transplant must have occurred at least 6 months prior to enrollment. patient must be on stable doses of immunosuppressive therapy for 3 months and deemed clinically stable by the investigator.
boolean
C0730400 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0022671 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0023911 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0018823 (UMLS CUI [4,2])
C0021079 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0205360 (UMLS CUI [5,3])
C0030705 (UMLS CUI [6,1])
C0205360 (UMLS CUI [6,2])
Serious Adverse Event | Adverse reaction to drug
Item
patients who experienced any adverse events considered serious and drug related in protocol cval489k2302.
boolean
C1519255 (UMLS CUI [1])
C0041755 (UMLS CUI [2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria applied to the study.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial